The DEA told congress it has the 'final authority' on any decision. Federal health officials in the US have acknowledged the ‘accepted medical use’ of cannabis for the first time, in documents confirming a recommendation that it be reclassified as a lower risk drug. The US Department of Health and Human Services (HHS) has released documents which confirm its recommendation that … [Read more...] about US federal health officials acknowledge ‘accepted medical use’ of cannabis
DEA
Drug Enforcement Administration Signals Intent to Reschedule Marijuana
On Dec. 19, 2023, Michael Miller, acting chief of the Drug Enforcement Administration (DEA) Office of Congressional Affairs, penned a letter to Congress advising that DEA is currently reviewing the Department of Health and Human Services’ (HHS) recommendations regarding rescheduling marijuana. Miller declared that “DEA has the final authority to schedule, reschedule, or … [Read more...] about Drug Enforcement Administration Signals Intent to Reschedule Marijuana
Industry Attorney Weighs in on Possible Cannabis Rescheduling Timeline: ‘It Normally Takes Years and Years for This to Get Done’
While some have speculated that the U.S. Drug Enforcement Administration (DEA) is on the cusp of deciding whether to accept or reject the Department of Health and Human Services (HHS) recommendation to reschedule cannabis under the Controlled Substances Act (CSA), Shane Pennington, partner at Porter Wright Morris & Arthur LLP, has a different perspective. He believes it … [Read more...] about Industry Attorney Weighs in on Possible Cannabis Rescheduling Timeline: ‘It Normally Takes Years and Years for This to Get Done’
US Congressman Urges DEA to Expedite Rescheduling Cannabis
Another U.S. congressman is putting pressure on the Drug Enforcement Administration (DEA) to follow through on a presidential request regarding cannabis reform. Rep. Steve Cohen, D-Tenn., wrote a letter Jan. 4 to DEA Administrator Anne Milgram urging her “in the strongest possible way” to act expeditiously on the Aug. 29 Department of Health and Human Services … [Read more...] about US Congressman Urges DEA to Expedite Rescheduling Cannabis
DEA Notice Shows Increase in Research Amounts for THC, Psilocybin, DMT, and More
The Drug Enforcement Agency (DEA) posted a notice on the Federal Register on Jan. 3, which includes the most recent breakdown of Schedule I Substances in its 2024 aggregate production quotas (APQ), as well as a wide variety of public comments and DEA responses. According to a Federal Register article published in November 2023, delta-9 THC (referred to as “d-9-THC” on the list) … [Read more...] about DEA Notice Shows Increase in Research Amounts for THC, Psilocybin, DMT, and More
Former US Attorneys Urge Federal Officials to Reject Cannabis Rescheduling Recommendation
The Dec. 13 letter, addressed to U.S. Attorney General Merrick Garland and Drug Enforcement Administration (DEA) Administrator Anne Milgram and signed by 29 former attorneys, comes in response to the U.S. Health and Human Services’ (HHS) August recommendation that cannabis be reclassified under the Controlled Substances Act (CSA). HHS still has not confirmed publicly the … [Read more...] about Former US Attorneys Urge Federal Officials to Reject Cannabis Rescheduling Recommendation
DEA warns Georgia to cancel plans to become first state to allow pharmacies to sell medical marijuana
The U.S. Drug Enforcement Administration is warning Georgia not to move forward with its plan to become the first state to allow pharmacies to distribute medical marijuana. DEA officials told pharmacies that dispensing medical marijuana would violate federal law. The Georgia Access to Medical Cannabis Commission, which oversees the state's medical marijuana industry, said it … [Read more...] about DEA warns Georgia to cancel plans to become first state to allow pharmacies to sell medical marijuana
DEA Warns Georgia Pharmacies To Stop Selling Low-THC Cannabis Oil
Federal law enforcement agents sent a warning letter dated Nov. 27 to pharmacies across Georgia, warning them that dispensing and selling cannabis oil is illegal under federal law. The letter arrived a month into Georgia’s medical cannabis program. Last June, Georgia’s Board of Pharmacy released a set of regulations that enable the state’s independent pharmacies to dispense … [Read more...] about DEA Warns Georgia Pharmacies To Stop Selling Low-THC Cannabis Oil
Blunts: Congress’ Research Says Keep Weed Taxes Low
Earlier this month, the Congressional Research Service (CRS) released a report that recommended low federal cannabis taxes to avoid unfair pressure on the industry. According to the report, cannabis advocates who claim that legalizing the drug would provide a new tax revenue source for the government may not be considering the potential economic impact of overburdensome taxes … [Read more...] about Blunts: Congress’ Research Says Keep Weed Taxes Low
How this proposed change could dramatically shift U.S. marijuana policy
The Biden administration is considering a major shift in the federal government’s policy on marijuana. In late August, the Department of Health and Human Services recommended that the Drug Enforcement Administration reclassify cannabis from Schedule I to Schedule III under the Controlled Substances Act. The Food and Drug Administration has also concluded that marijuana should … [Read more...] about How this proposed change could dramatically shift U.S. marijuana policy
